BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10879095)

  • 1. [Analysis for hematopoietic disorder using DNA methylation as a molecular marker].
    Uchida T; Fukuda T
    Rinsho Ketsueki; 2000 May; 41(5):380-5. PubMed ID: 10879095
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor suppressor genes in normal and malignant hematopoiesis.
    Krug U; Ganser A; Koeffler HP
    Oncogene; 2002 May; 21(21):3475-95. PubMed ID: 12032783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of epigenetic changes in hematological malignancies.
    Lehmann U; Brakensiek K; Kreipe H
    Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of gene promoters in hematological neoplasia.
    Chim CS; Liang R; Kwong YL
    Hematol Oncol; 2002 Dec; 20(4):167-76. PubMed ID: 12469326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development.
    Sakashita K; Koike K; Kinoshita T; Shiohara M; Kamijo T; Taniguchi S; Kubota T
    J Clin Invest; 2001 Oct; 108(8):1195-204. PubMed ID: 11602627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in normal and malignant hematopoiesis.
    Celik H; Kramer A; Challen GA
    Int J Hematol; 2016 Jun; 103(6):617-26. PubMed ID: 26943352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.
    Reddy J; Shivapurkar N; Takahashi T; Parikh G; Stastny V; Echebiri C; Crumrine K; Zöchbauer-Müller S; Drach J; Zheng Y; Feng Z; Kroft SH; McKenna RW; Gazdar AF
    Oncogene; 2005 Jan; 24(4):732-6. PubMed ID: 15580314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies.
    Nagai H; Li Y; Hatano S; Toshihito O; Yuge M; Ito E; Utsumi M; Saito H; Kinoshita T
    Genes Chromosomes Cancer; 2003 Sep; 38(1):13-21. PubMed ID: 12874782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
    Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
    Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The roles of microRNAs in hematopoiesis and hematopoietic malignancies].
    Li X; Zhang JH; Huang SA
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):489-90. PubMed ID: 17845765
    [No Abstract]   [Full Text] [Related]  

  • 13. [P15(INK4B) gene methylation in malignant hematopoietic diseases].
    Wu Q; Guo X; Fan H; Zhou T; Tan G; Guo Q; Chen P; Zhang X; Luo G; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):644-6. PubMed ID: 11877040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The roles of DNA methylation in human neoplasms].
    Yuan YF; Li JQ; Yang ZL; Wang JP
    Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
    Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
    Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on demethylation therapy for hematology malignancy].
    Shen JZ; Zhou HR
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):355-6. PubMed ID: 16780731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on DNA methylation status of WT1 gene in its promoter region in hematologic malignancy cell lines].
    Zhao Y; Chen ZX; Hu SY; Cen JN; Gu WY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):517-20. PubMed ID: 16468326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification by epigenome analysis of novel molecular targets for therapy in hematopoietic malignancies].
    Nojima M
    Rinsho Ketsueki; 2011 Mar; 52(3):111-7. PubMed ID: 21471697
    [No Abstract]   [Full Text] [Related]  

  • 19. The fundamental role of epigenetics in hematopoietic malignancies.
    Galm O; Herman JG; Baylin SB
    Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [14-3-3sigma (stratifin), a potential tumor suppressor frequently inactivated by methylation in cancer of the breast].
    Jeanteur P
    Bull Cancer; 2000 Jul; 87(7-8):525. PubMed ID: 10969206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.